Feed/Investors/Lyfe Capital

Lyfe Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-01-09

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$411M

across 1 round

LATEST ROUND

Series A · $411M · 2025-01-09

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Verdiva Bio Verdiva Bio develops next-generation medicines aimed at treating obesity and cardiometabolic diseases.	Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$411M	2025-01-09	[ PART ]